CVE-2026-62436[This CNA information record relates to multiple CVEs; the text explains which aspects/vulnerabilities correspond to which CVE.] With the introduction of Grant Table v2 came the requirement to be abl…
Updated under an hour ago ()
Does this affect you?
It lists no affected products yet. Add what you run and Signals checks it as products are added.
No exploitation reported and no EPSS estimate yet.
[This CNA information record relates to multiple CVEs; the text explains which aspects/vulnerabilities correspond to which CVE.] With the introduction of Grant Table v2 came the requirement to be able to switch between versions. Switching from v1 to v2 reduces the number of valid grant references, as a bigger shared entry structure is then needed while the shared table doesn't change size. Switching from v2 back to v1 the status frames, which are separate in v2, go away. Code holding, but intermediately dropping and then re-acquiring the grant table lock, sometimes wrongly assumes that said properties wouldn't change across the window in time where the lock is not being held. The v1 -> v2 issue is CVE-2026-62435. The v2 -> v1 issue is CVE-2026-62436.
- CVSS
- 6.5 MEDIUM (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:L
- Weakness (CWE)
- CWE-362
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Not given
- NVD analysis
- Deferred
- Record last updated
- Jul 28, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
No affected products are listed yet.
References
- https://xenbits.xenproject.org/xsa/advisory-501.html
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.